Fingerprint
Dive into the research topics of 'Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer
Aman Buzdar, Charles Vogel, Lee Schwartzberg, August Garin, Alejandra Perez, James Ingle, Michele Houghton, Christopher Zergebel, Bill Kimball
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations